Clinical Trial Update: Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing 6 months versus 12 months of dual antiplatelet therapy after drug-eluting stent in STEMI, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Maasstad Hospital | Conditions: Myocardial Infarction, Cardiovascular Disease | Phase 4 | Status: COMPLETED